Post Profile

SBRT found safe for medically inoperable patients with NSCLC

(NRG Oncology) This study tested the safety of using SBRT at different dose levels for patients with centrally located NSCLC. NRG-RTOG 0813 tested SBRT on 110 patients with medically inoperable, centrally located NSCLC and found that higher does could be delivered with acceptable toxicity and produce outcomes similar to patients with peripheral disease.
read more


Related Posts

SBRT For Medically Inoperable Early Stage Lung Cancer A Key Topic For Elekta Presenters At Lung Cancer Conference

Health : Medical News Today

During the 14th World Conference on Lung Cancer, leading users of Elekta Stereotactic Body Radiation Therapy (SBRT) technology presented their findings on the use of SBRT to treat early stage, non-small cell lung cancer (NSCLC). The...

Shortened radiation therapy schedule effective in patients with low-risk prostate cancer

Diseases & Conditions / Cancer : EurekAlert: Cancer

(NRG Oncology) NRG Oncology investigators found delivering higher doses of radiation therapy over 13 fewer days than conventional therapy was safe, more convenient for patients, and was associated with lower costs and similar qualit...

In Stage I Non-Small Cell Lung Cancer, Comparable Patterns Of Failure Exist Between SBRT, Lobectomy Or Pneumonectomy

Health : Medical News Today

For patients with medically operable clinical stage I non-small-cell lung cancer (NSCLC), lobectomy or pneumonectomy is the standard approach. For patients with medically inoperable stage I NSCLC, stereotactic body radiotherapy (SBR...

IMRT associated with reduction in patient reported xerostomia

Diseases & Conditions / Cancer : EurekAlert: Cancer

(NRG Oncology) A pooled analysis of data from NRG Oncology studies RTOG 0129 and 0522 compared intensity-modulated radiotherapy (IMRT) with three-dimensional conformal radiotherapy for patients treated for locally advanced head and ...

SBRT for early stage & centrally located non-small cell lung cancer is well tolerated

Academics / General Science : Science Codex

SAN ANTONIO--Toxicity results of the phase I/II NRG Oncology/RTOG 0813 trial evaluating the use of stereotactic body radiotherapy (SBRT) for treating patients who are not surgical candidates and have lung cancer tumors that are loca...


Copyright © 2016 Regator, LLC